FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MG0J133

Market Closed - Börse Stuttgart 09:49:56 2024-05-24 am EDT
9.74 EUR -15.08% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-34.89%
1 month-33.52%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 9.74 -15.08%
24-05-23 11.47 +7.10%
24-05-22 10.71 -10.53%
24-05-21 11.97 -3.86%
24-05-20 12.45 +7.05%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 09:49 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG0J13
ISINDE000MG0J133
Date issued 2024-03-20
Strike 296.1 p
Maturity Unlimited
Parity 0.04 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.19
Lowest since issue 9.74
Spread 0.1
Spread %1.10%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.23 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.07%
Consensus